Prostaglandin D2 inhibits the aggregation of human platelets
Generate an AI Snapshot to get a quick, structured summary of this paper.
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Prostaglandin D2, heretofore considered to be biologically inactive, was found to be more than twice as potent as prostaglandsin E1 as an inhibitor of aggregation in human citrated platelet-rich plasma.
Abstract
Prostaglandin D2, heretofore considered to be biologically inactive, was found to be more than twice as potent as prostaglandin E1 as an inhibitor of aggregation in human citrated platelet-rich plasma. It was much less potent than prostaglandin E1 in rabbit or rat platelet-rich plasma. This prostaglandin, or a derivative of it, may prove to be of greater value than prostaglandin E1 in maintaining the viability of stored platelets and as an antithrombotic agent.
